Aridis: Aridis's AR-301 monoclonal antibody to receive FDA QIDP designation
US FDA granted the IgG1 monoclonal antibody the first qualified infectious disease product (QIDP) designation.
Read full article »
Aridis is a California-based biopharmaceutical company that discovers and develops novel anti-infective therapies for the treatment of respiratory infections.
Read more